Nipecotic acid (mM/ml), GABA reuptake inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 129.16 Da, Purity >98%. GABA reuptake inhibitor. Achieve your results faster with highly validated, pure and trusted compounds.
View Alternative Names
BGT-1, Betaine/GABA transporter 1, D(1A) dopamine receptor, D1A dopamine receptor, DADR, DRD 1A, DRD1_HUMAN, Dopamine D1 receptor, GABA transport protein, GABATHG, GABATR, GABT 1, GABT3, GAT-1, GAT-2, GAT-3, Gamma aminobutyric acid transporter, Na(+)/Cl(-) betaine/GABA transporter, S6A11_HUMAN, S6A12_HUMAN, S6A13_HUMAN, SC6A1_HUMAN, SLC6A13, Slc6a1, Slc6a11, Slc6a12, Sodium- and chloride-dependent GABA transporter 1, Sodium- and chloride-dependent GABA transporter 2, Sodium- and chloride-dependent GABA transporter 3, Sodium- and chloride-dependent betaine transporter, Solute carrier family 6 (Neurotransmitter transporter, GABA), member 13, Solute carrier family 6 (neurotransmitter transporter GABA) member 1, Solute carrier family 6 (neurotransmitter transporter), member 12, Solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12, Solute carrier family 6 member 1, Solute carrier family 6 member 11, Solute carrier family 6 member 12, Solute carrier family 6 member 13, dopamine receptor D1
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
The Journal of neuroscience : the official journal of the Society for Neuroscience 33:14850-68 PubMed24027285
2013
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com